 | • レポートコード：QYR9ST03945 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、髄膜炎菌コンジュゲートの世界市場について調査・分析し、髄膜炎菌コンジュゲートの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（メナクトラ、メンベオ、NeisVac-C、ニメンリクス、その他）、用途別（子ども、プレティーンまたは10代、大人）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の髄膜炎菌コンジュゲート市場動向 ・主要企業別マーケットシェア ・髄膜炎菌コンジュゲートの種類別市場規模2014-2019 （メナクトラ、メンベオ、NeisVac-C、ニメンリクス、その他） ・髄膜炎菌コンジュゲートの用途別市場規模2014-2019 （子ども、プレティーンまたは10代、大人） ・髄膜炎菌コンジュゲートの北米市場：主要企業・種類別/用途別市場規模 ・髄膜炎菌コンジュゲートのヨーロッパ市場：主要企業・種類別/用途別市場規模 ・髄膜炎菌コンジュゲートの中国市場：主要企業・種類別/用途別市場規模 ・髄膜炎菌コンジュゲートの日本国内市場：主要企業・種類別/用途別市場規模 ・髄膜炎菌コンジュゲートの東南アジア市場：主要企業・種類別/用途別市場規模 ・髄膜炎菌コンジュゲートのインド市場：主要企業・種類別/用途別市場規模 ・髄膜炎菌コンジュゲートの中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Sanofi Pasteur、Pfizer、Glaxo Smith Kline、Hualan Biological Engineering、JN International Medical Corporation、Baxter International、Merck、Serum Institute of India、Biomed、Novartis） ・髄膜炎菌コンジュゲートの市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Meningococcal disease can become life threatening quickly, and teens are at higher risk of getting it. It’s a leading cause of bacterial meningitis in teens. Meningitis is a dangerous inflammation of the lining of the brain and spinal cord. Two meningitis vaccines protects against four types of meningococcal disease.In 2018, the global Meningococcal Conjugate market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Meningococcal Conjugate status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Meningococcal Conjugate development in United States, Europe and China.
The key players covered in this study
Sanofi Pasteur
Pfizer
Glaxo Smith Kline
Hualan Biological Engineering
JN International Medical Corporation
Baxter International
Merck
Serum Institute of India
Biomed
Novartis
Market segment by Type, the product can be split into
Menactra
Menveo
NeisVac-C
Nimenrix
Others
Market segment by Application, split into
Children
Preteens or Teens
Adults
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Meningococcal Conjugate status, future forecast, growth opportunity, key market and key players.
To present the Meningococcal Conjugate development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Meningococcal Conjugate are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Meningococcal Conjugate Market Size Growth Rate by Type (2014-2025)
1.4.2 Menactra
1.4.3 Menveo
1.4.4 NeisVac-C
1.4.5 Nimenrix
1.4.6 Others
1.5 Market by Application
1.5.1 Global Meningococcal Conjugate Market Share by Application (2014-2025)
1.5.2 Children
1.5.3 Preteens or Teens
1.5.4 Adults
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Meningococcal Conjugate Market Size
2.2 Meningococcal Conjugate Growth Trends by Regions
2.2.1 Meningococcal Conjugate Market Size by Regions (2014-2025)
2.2.2 Meningococcal Conjugate Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Meningococcal Conjugate Market Size by Manufacturers
3.1.1 Global Meningococcal Conjugate Revenue by Manufacturers (2014-2019)
3.1.2 Global Meningococcal Conjugate Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Meningococcal Conjugate Market Concentration Ratio (CR5 and HHI)
3.2 Meningococcal Conjugate Key Players Head office and Area Served
3.3 Key Players Meningococcal Conjugate Product/Solution/Service
3.4 Date of Enter into Meningococcal Conjugate Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Meningococcal Conjugate Market Size by Type (2014-2019)
4.2 Global Meningococcal Conjugate Market Size by Application (2014-2019)
5 United States
5.1 United States Meningococcal Conjugate Market Size (2014-2019)
5.2 Meningococcal Conjugate Key Players in United States
5.3 United States Meningococcal Conjugate Market Size by Type
5.4 United States Meningococcal Conjugate Market Size by Application
6 Europe
6.1 Europe Meningococcal Conjugate Market Size (2014-2019)
6.2 Meningococcal Conjugate Key Players in Europe
6.3 Europe Meningococcal Conjugate Market Size by Type
6.4 Europe Meningococcal Conjugate Market Size by Application
7 China
7.1 China Meningococcal Conjugate Market Size (2014-2019)
7.2 Meningococcal Conjugate Key Players in China
7.3 China Meningococcal Conjugate Market Size by Type
7.4 China Meningococcal Conjugate Market Size by Application
8 Japan
8.1 Japan Meningococcal Conjugate Market Size (2014-2019)
8.2 Meningococcal Conjugate Key Players in Japan
8.3 Japan Meningococcal Conjugate Market Size by Type
8.4 Japan Meningococcal Conjugate Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Meningococcal Conjugate Market Size (2014-2019)
9.2 Meningococcal Conjugate Key Players in Southeast Asia
9.3 Southeast Asia Meningococcal Conjugate Market Size by Type
9.4 Southeast Asia Meningococcal Conjugate Market Size by Application
10 India
10.1 India Meningococcal Conjugate Market Size (2014-2019)
10.2 Meningococcal Conjugate Key Players in India
10.3 India Meningococcal Conjugate Market Size by Type
10.4 India Meningococcal Conjugate Market Size by Application
11 Central & South America
11.1 Central & South America Meningococcal Conjugate Market Size (2014-2019)
11.2 Meningococcal Conjugate Key Players in Central & South America
11.3 Central & South America Meningococcal Conjugate Market Size by Type
11.4 Central & South America Meningococcal Conjugate Market Size by Application
12 International Players Profiles
12.1 Sanofi Pasteur
12.1.1 Sanofi Pasteur Company Details
12.1.2 Company Description and Business Overview
12.1.3 Meningococcal Conjugate Introduction
12.1.4 Sanofi Pasteur Revenue in Meningococcal Conjugate Business (2014-2019)
12.1.5 Sanofi Pasteur Recent Development
12.2 Pfizer
12.2.1 Pfizer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Meningococcal Conjugate Introduction
12.2.4 Pfizer Revenue in Meningococcal Conjugate Business (2014-2019)
12.2.5 Pfizer Recent Development
12.3 Glaxo Smith Kline
12.3.1 Glaxo Smith Kline Company Details
12.3.2 Company Description and Business Overview
12.3.3 Meningococcal Conjugate Introduction
12.3.4 Glaxo Smith Kline Revenue in Meningococcal Conjugate Business (2014-2019)
12.3.5 Glaxo Smith Kline Recent Development
12.4 Hualan Biological Engineering
12.4.1 Hualan Biological Engineering Company Details
12.4.2 Company Description and Business Overview
12.4.3 Meningococcal Conjugate Introduction
12.4.4 Hualan Biological Engineering Revenue in Meningococcal Conjugate Business (2014-2019)
12.4.5 Hualan Biological Engineering Recent Development
12.5 JN International Medical Corporation
12.5.1 JN International Medical Corporation Company Details
12.5.2 Company Description and Business Overview
12.5.3 Meningococcal Conjugate Introduction
12.5.4 JN International Medical Corporation Revenue in Meningococcal Conjugate Business (2014-2019)
12.5.5 JN International Medical Corporation Recent Development
12.6 Baxter International
12.6.1 Baxter International Company Details
12.6.2 Company Description and Business Overview
12.6.3 Meningococcal Conjugate Introduction
12.6.4 Baxter International Revenue in Meningococcal Conjugate Business (2014-2019)
12.6.5 Baxter International Recent Development
12.7 Merck
12.7.1 Merck Company Details
12.7.2 Company Description and Business Overview
12.7.3 Meningococcal Conjugate Introduction
12.7.4 Merck Revenue in Meningococcal Conjugate Business (2014-2019)
12.7.5 Merck Recent Development
12.8 Serum Institute of India
12.8.1 Serum Institute of India Company Details
12.8.2 Company Description and Business Overview
12.8.3 Meningococcal Conjugate Introduction
12.8.4 Serum Institute of India Revenue in Meningococcal Conjugate Business (2014-2019)
12.8.5 Serum Institute of India Recent Development
12.9 Biomed
12.9.1 Biomed Company Details
12.9.2 Company Description and Business Overview
12.9.3 Meningococcal Conjugate Introduction
12.9.4 Biomed Revenue in Meningococcal Conjugate Business (2014-2019)
12.9.5 Biomed Recent Development
12.10 Novartis
12.10.1 Novartis Company Details
12.10.2 Company Description and Business Overview
12.10.3 Meningococcal Conjugate Introduction
12.10.4 Novartis Revenue in Meningococcal Conjugate Business (2014-2019)
12.10.5 Novartis Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Meningococcal Conjugate Key Market Segments
Table Key Players Meningococcal Conjugate Covered
Table Global Meningococcal Conjugate Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Meningococcal Conjugate Market Size Market Share by Type 2014-2025
Figure Menactra Figures
Table Key Players of Menactra
Figure Menveo Figures
Table Key Players of Menveo
Figure NeisVac-C Figures
Table Key Players of NeisVac-C
Figure Nimenrix Figures
Table Key Players of Nimenrix
Figure Others Figures
Table Key Players of Others
Table Global Meningococcal Conjugate Market Size Growth by Application 2014-2025 (Million US$)
Figure Children Case Studies
Figure Preteens or Teens Case Studies
Figure Adults Case Studies
Figure Meningococcal Conjugate Report Years Considered
Table Global Meningococcal Conjugate Market Size 2014-2025 (Million US$)
Figure Global Meningococcal Conjugate Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Meningococcal Conjugate Market Size by Regions 2014-2025 (Million US$)
Table Global Meningococcal Conjugate Market Size by Regions 2014-2019 (Million US$)
Table Global Meningococcal Conjugate Market Share by Regions 2014-2019
Figure Global Meningococcal Conjugate Market Share by Regions 2014-2019
Figure Global Meningococcal Conjugate Market Share by Regions 2019
Table Market Top Trends
Table Global Meningococcal Conjugate Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Meningococcal Conjugate Market Share by Manufacturers (2014-2019)
Figure Global Meningococcal Conjugate Market Share by Manufacturers in 2018
Table Global Meningococcal Conjugate Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Meningococcal Conjugate Product/Solution/Service
Table Date of Enter into Meningococcal Conjugate Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Meningococcal Conjugate Market Size by Type (2014-2019) (Million US$)
Table Global Meningococcal Conjugate Market Size Share by Type (2014-2019)
Figure Global Meningococcal Conjugate Market Size Market Share by Type (2014-2019)
Table Global Meningococcal Conjugate Market Size by Application (2014-2019) (Million US$)
Table Global Meningococcal Conjugate Market Size Share by Application (2014-2019)
Figure Global Meningococcal Conjugate Market Size Market Share by Application (2014-2019)
Figure Global Meningococcal Conjugate Revenue Market Share by Application in 2018
Figure United States Meningococcal Conjugate Market Size 2014-2019 (Million US$)
Table United States Key Players Meningococcal Conjugate Revenue (2018-2019) (Million US$)
Table United States Key Players Meningococcal Conjugate Market Share (2018-2019)
Table United States Meningococcal Conjugate Market Size by Type (2014-2019) (Million US$)
Table United States Meningococcal Conjugate Market Share by Type (2014-2019)
Table United States Meningococcal Conjugate Market Size by Application (2014-2019) (Million US$)
Table United States Meningococcal Conjugate Market Share by Application (2014-2019)
Figure Europe Meningococcal Conjugate Market Size 2014-2019 (Million US$)
Table Europe Key Players Meningococcal Conjugate Revenue (2018-2019) (Million US$)
Table Europe Key Players Meningococcal Conjugate Market Share (2018-2019)
Table Europe Meningococcal Conjugate Market Size by Type (2014-2019) (Million US$)
Table Europe Meningococcal Conjugate Market Share by Type (2014-2019)
Table Europe Meningococcal Conjugate Market Size by Application (2014-2019) (Million US$)
Table Europe Meningococcal Conjugate Market Share by Application (2014-2019)
Figure China Meningococcal Conjugate Market Size 2014-2019 (Million US$)
Table China Key Players Meningococcal Conjugate Revenue (2018-2019) (Million US$)
Table China Key Players Meningococcal Conjugate Market Share (2018-2019)
Table China Meningococcal Conjugate Market Size by Type (2014-20189) (Million US$)
Table China Meningococcal Conjugate Market Share by Type (2014-2019)
Table China Meningococcal Conjugate Market Size by Application (2014-2019) (Million US$)
Table China Meningococcal Conjugate Market Share by Application (2014-2019)
Figure Japan Meningococcal Conjugate Market Size 2014-2019 (Million US$)
Table Japan Key Players Meningococcal Conjugate Revenue (2018-2019) (Million US$)
Table Japan Key Players Meningococcal Conjugate Market Share (2018-2019)
Table Japan Meningococcal Conjugate Market Size by Type (2014-2019) (Million US$)
Table Japan Meningococcal Conjugate Market Share by Type (2014-2019)
Table Japan Meningococcal Conjugate Market Size by Application (2014-2019) (Million US$)
Table Japan Meningococcal Conjugate Market Share by Application (2014-2019)
Figure Southeast Asia Meningococcal Conjugate Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Meningococcal Conjugate Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Meningococcal Conjugate Market Share (2018-2019)
Table Southeast Asia Meningococcal Conjugate Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Meningococcal Conjugate Market Share by Type (2014-2019)
Table Southeast Asia Meningococcal Conjugate Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Meningococcal Conjugate Market Share by Application (2014-2019)
Figure India Meningococcal Conjugate Market Size 2014-2019 (Million US$)
Table India Key Players Meningococcal Conjugate Revenue (2018-2019) (Million US$)
Table India Key Players Meningococcal Conjugate Market Share (2018-2019)
Table India Meningococcal Conjugate Market Size by Type (2014-2019) (Million US$)
Table India Meningococcal Conjugate Market Share by Type (2014-2019)
Table India Meningococcal Conjugate Market Size by Application (2014-2019) (Million US$)
Table India Meningococcal Conjugate Market Share by Application (2014-2019)
Figure Central & South America Meningococcal Conjugate Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Meningococcal Conjugate Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Meningococcal Conjugate Market Share (2018-2019)
Table Central & South America Meningococcal Conjugate Market Size by Type (2014-2019) (Million US$)
Table Central & South America Meningococcal Conjugate Market Share by Type (2014-2019)
Table Central & South America Meningococcal Conjugate Market Size by Application (2014-2019) (Million US$)
Table Central & South America Meningococcal Conjugate Market Share by Application (2014-2019)
Table Sanofi Pasteur Company Details
Table Sanofi Pasteur Revenue in Meningococcal Conjugate Business (2014-2019) (Million US$)
Figure Sanofi Pasteur Revenue Growth Rate in Meningococcal Conjugate Business (2014-2019)
Table Sanofi Pasteur Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Meningococcal Conjugate Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Meningococcal Conjugate Business (2014-2019)
Table Pfizer Recent Development
Table Glaxo Smith Kline Company Details
Table Glaxo Smith Kline Revenue in Meningococcal Conjugate Business (2014-2019)(Million US$)
Figure Glaxo Smith Kline Revenue Growth Rate in Meningococcal Conjugate Business (2014-2019)
Table Glaxo Smith Kline Recent Development
Table Hualan Biological Engineering Company Details
Table Hualan Biological Engineering Revenue in Meningococcal Conjugate Business (2014-2019)(Million US$)
Figure Hualan Biological Engineering Revenue Growth Rate in Meningococcal Conjugate Business (2014-2019)
Table Hualan Biological Engineering Recent Development
Table JN International Medical Corporation Company Details
Table JN International Medical Corporation Revenue in Meningococcal Conjugate Business (2014-2019)(Million US$)
Figure JN International Medical Corporation Revenue Growth Rate in Meningococcal Conjugate Business (2014-2019)
Table JN International Medical Corporation Recent Development
Table Baxter International Company Details
Table Baxter International Revenue in Meningococcal Conjugate Business (2014-2019)(Million US$)
Figure Baxter International Revenue Growth Rate in Meningococcal Conjugate Business (2014-2019)
Table Baxter International Recent Development
Table Merck Company Details
Table Merck Revenue in Meningococcal Conjugate Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Meningococcal Conjugate Business (2014-2019)
Table Merck Recent Development
Table Serum Institute of India Company Details
Table Serum Institute of India Revenue in Meningococcal Conjugate Business (2014-2019)(Million US$)
Figure Serum Institute of India Revenue Growth Rate in Meningococcal Conjugate Business (2014-2019)
Table Serum Institute of India Recent Development
Table Biomed Company Details
Table Biomed Revenue in Meningococcal Conjugate Business (2014-2019)(Million US$)
Figure Biomed Revenue Growth Rate in Meningococcal Conjugate Business (2014-2019)
Table Biomed Recent Development
Table Novartis Company Details
Table Novartis Revenue in Meningococcal Conjugate Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Meningococcal Conjugate Business (2014-2019)
Table Novartis Recent Development
Table Global Meningococcal Conjugate Market Size by Regions (Million US$) 2019-2025
Figure Global Meningococcal Conjugate Market Size Share by Regions (2019-2025)
Figure Global Meningococcal Conjugate Market Size Share by Regions in 2025
Figure United States Meningococcal Conjugate Market Size Forecast (2019-2025)(Million USD)
Figure Europe Meningococcal Conjugate Market Size Forecast (2019-2025)(Million USD)
Figure China Meningococcal Conjugate Market Size Forecast (2019-2025)(Million USD)
Figure Japan Meningococcal Conjugate Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Meningococcal Conjugate Market Size Forecast (2019-2025)(Million USD)
Figure India Meningococcal Conjugate Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Meningococcal Conjugate Market Size Forecast (2019-2025)(Million USD)
Table Global Meningococcal Conjugate Market Size by Product (2019-2025) (Million US$)
Figure Global Meningococcal Conjugate Market Size by Product (2019-2025)
Figure Global Meningococcal Conjugate Market Size by Product in 2025
Table Global Meningococcal Conjugate Market Size by Application (2019-2025) (Million US$)
Figure Global Meningococcal Conjugate Market Size by Application (2019-2025)
Figure Global Meningococcal Conjugate Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
髄膜炎菌性疾患治療の世界市場：インサイト・予測 Meningococcal disease is a severe infection of meninges, the thin layers of tissue covering brain and spinal cord, caused by the bacteria Neisseria meningitidis. This bacteria can also cause bloodstream infections (septicemia). Bacterial meningitis is severe because of rapid onset and a significant …- コンジュゲートワクチンの世界市場：インサイト・予測 Conjugate vaccines refer to those vaccines that contain bacterial capsule polysaccharide or the antigen attached or conjugated to a protein.This protein has a key role in enhancing the immunogenic property of the polysaccharide. These vaccines are mainly used to immunize infants and children against…
- 子供用風邪薬の世界市場：市場規模・現状・予測 A cough is a sudden, and often repetitively occurring, protective reflex which helps to clear the large breathing passages from fluids, irritants, foreign particles and microbes. Children Cough Medicine helps control your child’s cough plus thins and loosens mucus to relieve chest congestion so your…
- 家族・屋内エンターテイメントセンターの世界市場：市場規模・現状・予測 With continuous innovations in technological aspects, family entertainment centres are offering a diversified range of gaming options for their customers. New technologies such as virtual reality gaming, 3D technology, etc. are trending and consumers are preferring modern ways of entertainment over …
- 世界の高齢者健康補助食品市場：動向・競争分析 A dietary supplement is a manufactured product intended to supplement the diet when taken by mouth as a pill, capsule, tablet, or liquid.Health or dietary supplements include a vast group of products predominantly consumed for the purpose of enhancing the health and supplementing the diet. As the po…